Efficacy and Safety of AN2728 Topical Ointment to Treat Adolescents With Atopic Dermatitis
Public ClinicalTrials.gov record NCT01602341. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Four-Week, Bilateral Study of the Safety and Efficacy of Two Concentrations of AN2728 Ointment Administered Once or Twice a Day in Adolescents With Atopic Dermatitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine the safety and efficacy of AN2728 Topical Ointment, 2% and 0.5%, administered once a day (QD) or twice a day (BID), in the treatment of adolescents with atopic dermatitis (AD)
Study identification
- NCT ID
- NCT01602341
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 86 participants
Conditions and interventions
Conditions
Interventions
- AN2728 Topical Ointment, 2% QD Drug
- AN2728 Topical Ointment, 0.5% QD Drug
- AN2728 Topical Ointment, 2% BID Drug
- AN2728 Topical Ointment, 0.5% BID Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2012
- Primary completion
- Dec 31, 2012
- Completion
- Dec 31, 2012
- Last update posted
- Mar 5, 2017
2012 – 2013
United States locations
- U.S. sites
- 11
- U.S. states
- 11
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Anacor Investigational Site | Fremont | California | — | — |
| Anacor Investigational Site | Miami | Florida | — | — |
| Anacor Investigational Site | Lousiville | Kentucky | — | — |
| Anacor Investigational Site | Detroit | Michigan | — | — |
| Anacor Investigational Site | Albuquerque | New Mexico | — | — |
| Anacor Investigational Site | Stony Brook | New York | — | — |
| Anacor Investigational Site | High Point | North Carolina | — | — |
| Anacor Investigational Site | Portland | Oregon | — | — |
| Anacor Investigational Site | Knoxville | Tennessee | — | — |
| Anacor Investigational Site | Salt Lake City | Utah | — | — |
| Anacor Investigational Site | Norfolk | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01602341, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 5, 2017 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01602341 live on ClinicalTrials.gov.